SCHEMBL4377982

SCHEMBL4377982

NN(CCC12CC3CC(CC(C3)C1)C2)C(=O)NCCCc1ccncc1

nearest known ligand 0.48

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
P2RX7 Q99572 5/20 0.48
SMN1; SMN2 Q16637 2/20 0.47
ALDH1A1 P00352 4/20 0.44
CYP19A1 P11511 3/20 0.44
CYP17A1 P05093 2/20 0.44
MEN1 O00255 1/20 0.43
GAA P10253 1/20 0.43
HTT P42858 1/20 0.43
KMT2A Q03164 1/20 0.43
EPHX2 P34913 7/20 0.43
EPHX1 P07099 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL1677845 0.99 P2RX7 (0.47) P2RX7SMN1; SMN2ALDH1A1CYP19A1CYP17A1
SCHEMBL1678436 0.90 P2RX7 (0.51) P2RX7SMN1; SMN2ALDH1A1CYP19A1CYP17A1
Hydrochloric Acid SCHEMBL1677912 0.89 P2RX7 (0.50) P2RX7SMN1; SMN2ALDH1A1CYP19A1CYP17A1
SCHEMBL1678665 0.88 P2RX7 (0.49) P2RX7SMN1; SMN2ALDH1A1CYP19A1CYP17A1
SCHEMBL1678506 0.87 P2RX7 (0.46) P2RX7SMN1; SMN2ALDH1A1CYP19A1CYP17A1
SCHEMBL1679345 0.87 P2RX7 (0.48) P2RX7SMN1; SMN2ALDH1A1CYP19A1CYP17A1
Hydrochloric Acid SCHEMBL1678038 0.86 P2RX7 (0.46) P2RX7SMN1; SMN2ALDH1A1CYP19A1CYP17A1
SCHEMBL1678533 0.86 P2RX7 (0.47) P2RX7SMN1; SMN2ALDH1A1CYP19A1CYP17A1
SCHEMBL1677703 0.85 P2RX7 (0.46) P2RX7SMN1; SMN2ALDH1A1CYP19A1CYP17A1
SCHEMBL1677980 0.85 P2RX7 (0.46) P2RX7SMN1; SMN2ALDH1A1CYP19A1CYP17A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1743885-B1 1-[(adamantyl)alkyl]-3-[(pyridinyl)alkyl]urea compounds as TNF-.alpha inhibitors useful for autoimmune diseases SANTEN PHARMACEUTICAL CO LTD (JP) 2009-11-11 EP disclosed
EP-1743885-A2 TNF-Alpha Produktion Hemmer zur Behandlung von Autoimmunerkrankungen SANTEN PHARMACEUTICAL CO., LTD. (JP) 2007-01-17 EP disclosed